Who
Jan Stern Reed
Director
Company insider
Files Form 4 as: Director, GMR Solutions; Director, AngioDynamics; Director, Stepan; Director, Avita Medical; SVP, GC and Corp. Sec., Walgreens Boots Alliance.
In numbers
- Trades disclosed
- 54
- Buys
- 2
- Sells
- 0
- Bought
- $56K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 4
- First trade
- 27 Oct 2015
- Last trade
- 26 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 28 Aug 2026 | GMRS GMR Solutionsoption or derivative · Trucking & Logistics | SEC FORM 4 Code A | —976 at $0.00 | filing |
| 26 Aug 2026filed 28 Aug 2026 | GMRS GMR Solutionsoption or derivative · Trucking & Logistics | SEC FORM 4 Code A | —976 at $0.00 | filing |
| 15 Jul 2026filed 22 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code A | —11,887 at $0.00 | filing |
| 15 Jul 2026filed 22 Jul 2026 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code A | —11,887 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | GMRS GMR Solutionsoption or derivative · Trucking & Logistics | SEC FORM 4 Code A | —12,334 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | GMRS GMR Solutionsoption or derivative · Trucking & Logistics | SEC FORM 4 Code A | —12,334 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | SCL StepanChemicals | SEC FORM 4 Code A | $135K2,566 at $52.61 | filing |
| 8 May 2026filed 12 May 2026 | SCL StepanChemicals | SEC FORM 4 Code A | $135K2,566 at $52.61 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —22,214 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,133 at $0.00 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —16,133 at $0.00 | filing |
| 20 Jan 2026filed 4 Jun 2026 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —22,214 | filing |
| 16 Jul 2025filed 18 Jul 2025 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code A | —17,675 at $0.00 | filing |
| 12 May 2025filed 13 May 2025 | SCL StepanChemicals | SEC FORM 4 Code A | $136K2,500 at $54.26 | filing |
| 21 Jan 2025filed 5 Jun 2025 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —4,295 at $0.00 | filing |
| 21 Jan 2025filed 5 Jun 2025 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —10,022 | filing |
| 17 Jul 2024filed 19 Jul 2024 | ANGO AngioDynamicsMedical Devices | SEC FORM 4 Code A | —20,541 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | RCEL Avita Medicaloption or derivative · Medical Devices | SEC FORM 4 Code A | —3,943 at $0.00 | filing |
| 5 Jun 2024filed 6 Jun 2024 | RCEL Avita MedicalMedical Devices | SEC FORM 4 Code A | —9,200 | filing |
| 10 May 2024filed 14 May 2024 | SCL StepanChemicals | SEC FORM 4 Code A | $125K1,396 at $89.53 | filing |
News
Financial Analysis: Air Products and Chemicals (NYSE:APD) vs. Stepan (NYSE:SCL)SCL · tickerreport.com · 14 Oct 2026AngioDynamics (NASDAQ:ANGO) Given Buy Rating at Canaccord Genuity GroupANGO · themarketsdaily.com · 9 Oct 2026AngioDynamics (NASDAQ:ANGO) Issues FY 2027 Earnings GuidanceANGO · dailypolitical.com · 8 Oct 2026AngioDynamics Reiterates FY27 Outlook; Appoints Eric Honroth President And CEOANGO · rttnews.com · 8 Oct 2026
0 headlines in the last 90 days name Jan Stern Reed; 4 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.